High-dose bicalutamide monotherapy for the treatment of prostate cancer
Author:
Publisher
Elsevier BV
Subject
Urology
Reference9 articles.
1. Casodex: preclinical studies;Furr;Eur Urol,1990
2. The response of advanced prostatic cancer to a new non-steroidal antiandrogen: results of a multicenter open phase II study of Casodex;Newling;Eur Urol,1990
3. Update of monotherapy trials with the new anti-androgen Casodex (ICI 176,334);Iversen;Eur Urol,1994
4. The pharmacokinetics of Casodex in prostate cancer patients after single and during multiple dosing;Cockshott;Eur Urol,1990
5. A new non-steroidal anti-androgen;Denis;Prog Clin Biol Res,1989
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Serial [18F]-FDHT-PET to predict bicalutamide efficacy in patients with androgen receptor positive metastatic breast cancer;European Journal of Cancer;2021-02
2. Allosteric pathways in nuclear receptors — Potential targets for drug design;Pharmacology & Therapeutics;2018-03
3. Two New Oxodolastane Diterpenes from the Jamaican Macroalga Canistrocarpus cervicornis;Marine Drugs;2017-05-30
4. Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer;Cochrane Database of Systematic Reviews;2014-06-30
5. High-performance thin-layer chromatographic analysis of bicalutamide in bulk drug and liposomes;Journal of Planar Chromatography – Modern TLC;2009-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3